Ann L. MacDougall, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 5,000 shares at $14.54 ($73K) on 2019-12-12, disclosed to the SEC on 2019-12-12.
Open-market purchase of $73k OPNT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| OPNT | BUY | 2018-06-05 | $81K | — | Filing → |